160 related articles for article (PubMed ID: 18070457)
1. [Advances in anti-beta antibody treatment of Alzheimer's disease].
Zhang JH; Liang P
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):633-5. PubMed ID: 18070457
[No Abstract] [Full Text] [Related]
2. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
5. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.
Rygiel K
Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy for Alzheimer's disease].
Falkentoft AC; Hasselbalch SG
Ugeskr Laeger; 2016 Jan; 178(3):V07150588. PubMed ID: 26815584
[TBL] [Abstract][Full Text] [Related]
7. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle.
Niewoehner J; Bohrmann B; Collin L; Urich E; Sade H; Maier P; Rueger P; Stracke JO; Lau W; Tissot AC; Loetscher H; Ghosh A; Freskgård PO
Neuron; 2014 Jan; 81(1):49-60. PubMed ID: 24411731
[TBL] [Abstract][Full Text] [Related]
8. [Progress in developing anti-Alzheimer drugs].
Tabira T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):34P-36P. PubMed ID: 12491773
[TBL] [Abstract][Full Text] [Related]
9. [Current status of Alzheimer's disease immunotherapy and pharmacologic effect of BAN2401.].
Araki S
Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):21-5. PubMed ID: 20628209
[No Abstract] [Full Text] [Related]
10. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
[TBL] [Abstract][Full Text] [Related]
11. Vaccines: chasing the dream.
Schnabel J
Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
[No Abstract] [Full Text] [Related]
12. Selective neutralization of APP-C99 with monoclonal antibodies reduces the production of Alzheimer's Aβ peptides.
Houacine J; Bolmont T; Aeschbach L; Oulad-Abdelghani M; Fraering PC
Neurobiol Aging; 2012 Nov; 33(11):2704-14. PubMed ID: 22317957
[TBL] [Abstract][Full Text] [Related]
13. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
15. Anti-amyloid Therapy of Alzheimer's Disease: Current State and Prospects.
Kozin SA; Barykin EP; Mitkevich VA; Makarov AA
Biochemistry (Mosc); 2018 Sep; 83(9):1057-1067. PubMed ID: 30472944
[TBL] [Abstract][Full Text] [Related]
16. Generation and brain delivery of anti-aggregating antibodies against beta-amyloid plaques using phage display technology.
Solomon B; Frenkel D
J Neural Transm Suppl; 2002; (62):321-5. PubMed ID: 12456075
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's amyloid immunotherapy: quo vadis?
Gandy S; Heppner FL
Lancet Neurol; 2005 Aug; 4(8):452-3. PubMed ID: 16033686
[No Abstract] [Full Text] [Related]
18. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice.
Paganetti P; Reichwald J; Bleckmann D; Abramowski D; Ammaturo D; Barske C; Danner S; Molinari M; Müller M; Papin S; Rabe S; Schmid P; Staufenbiel M
Neurobiol Aging; 2013 Dec; 34(12):2866-78. PubMed ID: 23870837
[TBL] [Abstract][Full Text] [Related]
19. The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.
Ling S; Zhou J; Rudd JA; Hu Z; Fang M
Anat Rec (Hoboken); 2011 Aug; 294(8):1307-18. PubMed ID: 21717585
[TBL] [Abstract][Full Text] [Related]
20. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
